Literature DB >> 32576369

Socioeconomic Status and Differences in the Management and Outcomes of 6.6 Million US Patients With Acute Myocardial Infarction.

Andrija Matetic1, Aditya Bharadwaj2, Mohamed O Mohamed3, Yashasvi Chugh4, Sanjay Chugh5, Margot Minissian6, Amit Amin7, Harriette Van Spall8, David L Fischman9, Michael Savage9, Annabelle Santos Volgman10, Mamas A Mamas11.   

Abstract

Little is known about the impact of socioeconomic status (SES) on management strategies and in-hospital clinical outcomes in patients with acute myocardial infarction (AMI) and its subtypes, and whether these trends have changed over time. All AMI hospitalizations from the National Inpatient Sample (2004 to 2014) were analyzed and stratified by zip code-based median household income (MHI) into 4 quartiles (poorest to wealthiest): 0th to 25th, 26th to 50th, 51st to 75th, and 76th to 100th. Logistic regression was performed to examine the association between MHI and AMI management strategy and in-hospital clinical outcomes. A total of 6,603,709 AMI hospitalizations were analyzed. Patients in the lowest MHI group had more co-morbidities, a worse cardiovascular risk factor profile and were more likely to be female. Differences in receipt of invasive management were observed between the lowest and highest MHI quartiles, with the lowest MHI group less likely to undergo coronary angiography (63.4% vs 64.3%, p <0.001) and percutaneous coronary intervention (40.4% vs 44.3%, p <0.001) compared with the highest MHI group, especially in the STEMI subgroup. In multivariable analysis, the highest MHI group experienced better outcomes including lower risk (adjusted odds ratio; 95% confidence intervals) of mortality (0.88; 0.88 to 0.89), MACCE (0.91; 0.91 to 0.92) and acute ischemic stroke (0.90; 0.88 to 0.91), but higher all-cause bleeding (1.08; 1.06 to 1.09) in comparison to the lowest MHI group. In conclusion, the provision of invasive management for AMI in patients with lower SES is less than patients with higher SES and is associated with worse in-hospital clinical outcomes. This work highlights the importance of ensuring equity of access and care across all strata SES.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32576369     DOI: 10.1016/j.amjcard.2020.05.025

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Effect of Socio-Economic Status on Perioperative Outcomes After Robotic-Assisted Pulmonary Lobectomy.

Authors:  Anastasia Jermihov; Liwei Chen; Maria F Echavarria; Emily P Ng; Frank O Velez; Carla C Moodie; Joseph R Garrett; Jacques P Fontaine; Eric M Toloza
Journal:  Cureus       Date:  2022-06-22

2.  Socioeconomic Deprivation: An Important, Largely Unrecognized Risk Factor in Primary Prevention of Cardiovascular Disease.

Authors:  Dorien M Kimenai; Leah Pirondini; John Gregson; David Prieto; Stuart J Pocock; Pablo Perel; Tilly Hamilton; Paul Welsh; Archie Campbell; David J Porteous; Caroline Hayward; Naveed Sattar; Nicholas L Mills; Anoop S V Shah
Journal:  Circulation       Date:  2022-06-24       Impact factor: 39.918

3.  Body Mass Index and In-Hospital Management and Outcomes of Acute Myocardial Infarction.

Authors:  Sri Harsha Patlolla; Gayathri Gurumurthy; Pranathi R Sundaragiri; Wisit Cheungpasitporn; Saraschandra Vallabhajosyula
Journal:  Medicina (Kaunas)       Date:  2021-09-02       Impact factor: 2.948

4.  Socioeconomic status, cardiovascular risk profile, and premature coronary heart disease.

Authors:  Safi U Khan; Ryan T Nguyen; Zulqarnain Javed; Maninder Singh; Javier Valero-Elizondo; Miguel Cainzos-Achirica; Khurram Nasir
Journal:  Am J Prev Cardiol       Date:  2022-07-26

5.  Association of Socioeconomic Status With Outcomes and Care Quality in Patients Presenting With Undifferentiated Chest Pain in the Setting of Universal Health Care Coverage.

Authors:  Luke P Dawson; Emily Andrew; Ziad Nehme; Jason Bloom; Sinjini Biswas; Shelley Cox; David Anderson; Michael Stephenson; Jeffrey Lefkovits; Andrew J Taylor; David Kaye; Karen Smith; Dion Stub
Journal:  J Am Heart Assoc       Date:  2022-03-24       Impact factor: 6.106

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.